• 2017
  Sharma R, Harris VM, Cavett J, Kurien BT, Liu K, Koelsch KA, Fayaaz A, Chaudhari KS, Radfar L, Lewis D, Stone DU, Kaufman CE, Li S, Segal B, Wallace DJ, Weisman MH, Venuturupalli S, Kelly JA, Pons-Estel B, Jonsson R, Lu X, Gottenberg JE, Anaya JM, Cunninghame-Graham DS, Huang AJW, Brennan MT, Hughes P, Alevizos I, Miceli-Richard C, Keystone EC, Bykerk VP, Hirschfield G, Xie G, Nordmark G, Bucher SM, Eriksson P, Omdal R, Rhodus NL, Rischmueller M, Rohrer M, Wahren-Herlenius M, Witte T, Alarcon-Riquelme M, Mariette X, Lessard CJ, Harley JB, Ng WF, Rasmussen A, Sivils KL, Scofield RH, Rare X chromosome abnormalities in systemic lupus erythematosus and Sjögren’s syndrome, 2017 Jul;.
• 2017
  Li H, Reksten TR, Ice JA, Kelly JA, Adrianto I, Rasmussen A, Wang S, He B, Grundahl KM, Glenn SB, Miceli-Richard C, Bowman S, Lester S, Eriksson P, Eloranta ML, Brun JG, Gøransson LG, Harboe E, Guthridge JM, Kaufman KM, Kvarnström M, Cunninghame Graham DS, Patel K, Adler AJ, Farris AD, Brennan MT, Chodosh J, Gopalakrishnan R, Weisman MH, Venuturupalli S, Wallace DJ, Hefner KS, Houston GD, Huang AJW, Hughes PJ, Lewis DM, Radfar L, Vista ES, Edgar CE, Rohrer MD, Stone DU, Vyse TJ, Harley JB, Gaffney PM, James JA, Turner S, Alevizos I, Anaya JM, Rhodus NL, Segal BM, Montgomery CG, Scofield RH, Kovats S, Mariette X, Rönnblom L, Witte T, Rischmueller M, Wahren-Herlenius M, Omdal R, Jonsson R, Ng WF, , Nordmark G, Lessard CJ, Sivils KL, Identification of a Sjögren’s syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons, PLoS Genet. 2017 Jun;13(6):e1006820.
• 2017
  Hamze M, Meunier S, Karle A, Gdoura A, Goudet A, Szely N, Pallardy M, Carbonnel F, Spindeldreher S, Mariette X, Miceli-Richard C, Maillère B, Characterization of CD4 T Cell Epitopes of Infliximab and Rituximab Identified from Healthy Donors, Front Immunol 2017;8:500.
• 2017
  Rivière E, Arnaud L, Ebbo M, Allanore Y, Claudepierre P, Dernis E, Ziza JM, Miceli-Richard C, Philippe P, Richez C, Soubrier M, Belkhir R, Seror R, Mariette X, Pavy S, , Takayasu Arteritis and Spondyloarthritis: Coincidence or Association? A Study of 14 Cases, J. Rheumatol. 2017 Jul;44(7):1011-1017.
• 2017
  Cui J, Diogo D, Stahl EA, Canhao H, Mariette X, Greenberg JD, Okada Y, Pappas DA, Fulton RS, Tak PP, Nurmohamed MT, Lee A, Larson DE, Kurreeman F, Deluca TL, O'Laughlin M, Fronick CC, Fulton LL, Mardis ER, van der Horst-Bruinsma IE, Wolbink GJ, Gregersen PK, Kremer JM, Crusius JB, de Vries N, Huizinga TW, Fonseca JE, Miceli-Richard C, Karlson EW, Coenen MJ, Barton A, Plenge RM, Raychaudhuri S, Brief Report: The Role of Rare Protein-Coding Variants in Anti-Tumor Necrosis Factor Treatment Response in Rheumatoid Arthritis, 2017 Apr;69(4):735-741.
• 2017
  Miceli-Richard C, Dougados M, Tracking JAKs in spondyloarthritis: rationale and expectations, Ann. Rheum. Dis. 2017 Aug;76(8):1325-1326.
• 2017
  Navarro-Compán V, Ramiro S, Landewé R, Dougados M, Miceli-Richard C, Richette P, van der Heijde D, In patients with axial spondyloarthritis, inflammation on MRI of the spine is longitudinally related to disease activity only in men: 2 years of the axial spondyloarthritis DESIR cohort, Ann. Rheum. Dis. 2017 Mar;.
• 2016
  Sigaux J, Hamze M, Daien C, Morel J, Krzysiek R, Pallardy M, Maillere B, Mariette X, Miceli-Richard C, Immunogenicity of tocilizumab in patients with rheumatoid arthritis, Joint Bone Spine 2017 Jan;84(1):39-45.
• 2016
  Liu K, Kurien BT, Zimmerman SL, Kaufman KM, Taft DH, Kottyan LC, Lazaro S, Weaver CA, Ice JA, Adler AJ, Chodosh J, Radfar L, Rasmussen A, Stone DU, Lewis DM, Li S, Koelsch KA, Igoe A, Talsania M, Kumar J, Maier-Moore JS, Harris VM, Gopalakrishnan R, Jonsson R, Lessard JA, Lu X, Gottenberg JE, Anaya JM, Cunninghame-Graham DS, Huang AJW, Brennan MT, Hughes P, Illei GG, Miceli-Richard C, Keystone EC, Bykerk VP, Hirschfield G, Xie G, Ng WF, Nordmark G, Eriksson P, Omdal R, Rhodus NL, Rischmueller M, Rohrer M, Segal BM, Vyse TJ, Wahren-Herlenius M, Witte T, Pons-Estel B, Alarcon-Riquelme ME, Guthridge JM, James JA, Lessard CJ, Kelly JA, Thompson SD, Gaffney PM, Montgomery CG, Edberg JC, Kimberly RP, Alarcón GS, Langefeld CL, Gilkeson GS, Kamen DL, Tsao BP, McCune WJ, Salmon JE, Merrill JT, Weisman MH, Wallace DJ, Utset TO, Bottinger EP, Amos CI, Siminovitch KA, Mariette X, Sivils KL, Harley JB, Scofield RH, X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögren’s Syndrome, 2016 May;68(5):1290-1300.
• 2016
  Tomi AL, Belkhir R, Nocturne G, Desmoulins F, Berge E, Pavy S, Miceli-Richard C, Mariette X, Seror R, Brief Report: Monoclonal Gammopathy and Risk of Lymphoma and Multiple Myeloma in Patients With Primary Sjögren’s Syndrome, 2016 May;68(5):1245-50.
• 2016
  Harris VM, Sharma R, Cavett J, Kurien BT, Liu K, Koelsch KA, Rasmussen A, Radfar L, Lewis D, Stone DU, Kaufman CE, Li S, Segal B, Wallace DJ, Weisman MH, Venuturupalli S, Kelly JA, Alarcon-Riquelme ME, Pons-Estel B, Jonsson R, Lu X, Gottenberg JE, Anaya JM, Cunninghame-Graham DS, Huang AJW, Brennan MT, Hughes P, Alevizos I, Miceli-Richard C, Keystone EC, Bykerk VP, Hirschfield G, Xie G, Ng WF, Nordmark G, Bucher SM, Eriksson P, Omdal R, Rhodus NL, Rischmueller M, Rohrer M, Wahren-Herlenius M, Witte T, Mariette X, Lessard CJ, Harley JB, Sivils KL, Scofield RH, Klinefelter’s syndrome (47,XXY) is in excess among men with Sjögren’s syndrome, Clin. Immunol. 2016 07;168:25-29.
• 2016
  Vincent FB, Pavy S, Krzysiek R, Lequerré T, Sellam J, Taoufik Y, Mariette X, Miceli-Richard C, Effect of serum anti-tumour necrosis factor (TNF) drug trough concentrations and antidrug antibodies (ADAb) to further anti-TNF short-term effectiveness after switching in rheumatoid arthritis and axial spondyloarthritis, Joint Bone Spine 2016 Oct;83(5):595-7.
• 2016
  Seror R, Boudaoud S, Pavy S, Nocturne G, Schaeverbeke T, Saraux A, Chanson P, Gottenberg JE, Devauchelle-Pensec V, Tobón GJ, Mariette X, Miceli-Richard C, Increased Dickkopf-1 in Recent-onset Rheumatoid Arthritis is a New Biomarker of Structural Severity. Data from the ESPOIR Cohort, Sci Rep 2016 Jan;6:18421.
• 2015
  Rivière E, Ly B, Boudaoud S, Chavez H, Nocturne G, Chanson P, Miceli Richard C, Mariette X, Pitfalls for detecting interleukin-33 by ELISA in the serum of patients with primary Sjögren syndrome: comparison of different kits, Ann. Rheum. Dis. 2016 Mar;75(3):633-5.
• 2015
  Ruyssen-Witrand A, van Steenbergen HW, van Heemst J, Gourraud PA, Nigon D, Lukas C, Miceli-Richard C, Jamard B, Cambon-Thomsen A, Cantagrel A, Dieudé P, van der Helm-van Mil AH, Constantin A, A new classification of HLA-DRB1 alleles based on acid-base properties of the amino acids located at positions 13, 70 and 71: impact on ACPA status or structural progression, and meta-analysis on 1235 patients with rheumatoid from two cohorts (ESPOIR and EAC cohort), RMD Open 2015;1(1):e000099.
• 2015
  Miceli-Richard C, Enthesitis: The clue to the pathogenesis of spondyloarthritis?, Joint Bone Spine 2015 Dec;82(6):402-5.
• 2015
  Navarro-Compán V, Ramiro S, Landewé R, Dougados M, Miceli-Richard C, Richette P, van der Heijde D, Disease activity is longitudinally related to sacroiliac inflammation on MRI in male patients with axial spondyloarthritis: 2-years of the DESIR cohort, Ann. Rheum. Dis. 2016 May;75(5):874-8.
• 2015
  Briot K, Etcheto A, Miceli-Richard C, Dougados M, Roux C, Bone loss in patients with early inflammatory back pain suggestive of spondyloarthritis: results from the prospective DESIR cohort, Rheumatology (Oxford) 2016 Feb;55(2):335-42.
• 2015
  Nocturne G, Tarn J, Boudaoud S, Locke J, Miceli-Richard C, Hachulla E, Dubost JJ, Bowman S, Gottenberg JE, Criswell LA, Lessard CJ, Sivils KL, Carapito R, Bahram S, Seror R, Ng WF, Mariette X, Germline variation of TNFAIP3 in primary Sjögren’s syndrome-associated lymphoma, Ann. Rheum. Dis. 2016 Apr;75(4):780-3.
• 2015
  Nocturne G, Pavy S, Boudaoud S, Seror R, Goupille P, Chanson P, van der Heijde D, van Gaalen F, Berenbaum F, Mariette X, Briot K, Feydy A, Claudepierre P, Dieudé P, Nithitham J, Taylor KE, Criswell LA, Dougados M, Roux C, Miceli-Richard C, Increase in Dickkopf-1 Serum Level in Recent Spondyloarthritis. Data from the DESIR Cohort, PLoS ONE 2015;10(8):e0134974.
• 2015
  Miceli-Richard C, Wang-Renault SF, Boudaoud S, Busato F, Lallemand C, Bethune K, Belkhir R, Nocturne G, Mariette X, Tost J, Overlap between differentially methylated DNA regions in blood B lymphocytes and genetic at-risk loci in primary Sjögren’s syndrome, Ann. Rheum. Dis. 2016 May;75(5):933-40.
• 2015
  Miceli-Richard C, Taylor KE, Nititham J, Seror R, Nocturne G, Boudaoud S, Dieude P, Constantin A, Devauchelle-Pensec V, Tobón GJ, Mariette X, Criswell LA, Genetic contribution of DKK-1 polymorphisms to RA structural severity and DKK-1 level of expression, Ann. Rheum. Dis. 2015 Jul;74(7):1480-1.
• 2014
  Miceli-Richard C, Epigenetics and lupus, Joint Bone Spine 2015 Mar;82(2):90-3.
• 2014
  Helliwell P, Coates L, Chandran V, Gladman D, de Wit M, FitzGerald O, Kavanaugh A, Strand V, Mease PJ, Boehncke WH, Langley RG, Lubrano E, Maccarone M, Schulze-Koops H, Miceli-Richard C, Queiro R, Qualifying unmet needs and improving standards of care in psoriatic arthritis, Arthritis Care Res (Hoboken) 2014 Dec;66(12):1759-66.
• 2014
  Dougados M, Wood E, Combe B, Schaeverbeke T, Miceli-Richard C, Berenbaum F, Koppiker N, Dubanchet A, Logeart I, Evaluation of the nonsteroidal anti-inflammatory drug-sparing effect of etanercept in axial spondyloarthritis: results of the multicenter, randomized, double-blind, placebo-controlled SPARSE study, Arthritis Res. Ther. 2014 Nov;16(6):481.
• 2014
  Kottyan LC, Zoller EE, Bene J, Lu X, Kelly JA, Rupert AM, Lessard CJ, Vaughn SE, Marion M, Weirauch MT, Namjou B, Adler A, Rasmussen A, Glenn S, Montgomery CG, Hirschfield GM, Xie G, Coltescu C, Amos C, Li H, Ice JA, Nath SK, Mariette X, Bowman S, , Rischmueller M, Lester S, Brun JG, Gøransson LG, Harboe E, Omdal R, Cunninghame-Graham DS, Vyse T, Miceli-Richard C, Brennan MT, Lessard JA, Wahren-Herlenius M, Kvarnström M, Illei GG, Witte T, Jonsson R, Eriksson P, Nordmark G, Ng WF, , Anaya JM, Rhodus NL, Segal BM, Merrill JT, James JA, Guthridge JM, Scofield RH, Alarcon-Riquelme M, Bae SC, Boackle SA, Criswell LA, Gilkeson G, Kamen DL, Jacob CO, Kimberly R, Brown E, Edberg J, Alarcón GS, Reveille JD, Vilá LM, Petri M, Ramsey-Goldman R, Freedman BI, Niewold T, Stevens AM, Tsao BP, Ying J, Mayes MD, Gorlova OY, Wakeland W, Radstake T, Martin E, Martin J, Siminovitch K, Moser Sivils KL, Gaffney PM, Langefeld CD, Harley JB, Kaufman KM, The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share, Hum. Mol. Genet. 2015 Jan;24(2):582-96.
• 2014
  Dougados M, van der Heijde D, Sieper J, Braun J, Maksymowych WP, Citera G, Miceli-Richard C, Wei JC, Pedersen R, Bonin R, Rahman MU, Logeart I, Wajdula J, Koenig AS, Vlahos B, Alvarez D, Bukowski JF, Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized, double-blind, placebo-controlled trial, 2014 Aug;66(8):2091-102.
• 2014
  Miceli-Richard C, Criswell LA, Genetic, genomic and epigenetic studies as tools for elucidating disease pathogenesis in primary Sjögren’s syndrome, Expert Rev Clin Immunol 2014 Apr;10(4):437-44.
• 2014
  Okada Y, Diogo D, Greenberg JD, Mouassess F, Achkar WA, Fulton RS, Denny JC, Gupta N, Mirel D, Gabriel S, Li G, Kremer JM, Pappas DA, Carroll RJ, Eyler AE, Trynka G, Stahl EA, Cui J, Saxena R, Coenen MJ, Guchelaar HJ, Huizinga TW, Dieudé P, Mariette X, Barton A, Canhão H, Fonseca JE, de Vries N, Tak PP, Moreland LW, Bridges SL, Miceli-Richard C, Choi HK, Kamatani Y, Galan P, Lathrop M, Raj T, De Jager PL, Raychaudhuri S, Worthington J, Padyukov L, Klareskog L, Siminovitch KA, Gregersen PK, Mardis ER, Arayssi T, Kazkaz LA, Plenge RM, Integration of sequence data from a Consanguineous family with genetic data from an outbred population identifies PLB1 as a candidate rheumatoid arthritis risk gene, PLoS ONE 2014;9(2):e87645.
• 2014
  Wendling D, Lukas C, Paccou J, Claudepierre P, Carton L, Combe B, Goupille P, Guillemin F, Hudry C, Miceli-Richard C, Dougados M, , Recommendations of the French Society for Rheumatology (SFR) on the everyday management of patients with spondyloarthritis, Joint Bone Spine 2014 Jan;81(1):6-14.
• 2014
  Gong YZ, Nititham J, Taylor K, Miceli-Richard C, Sordet C, Wachsmann D, Bahram S, Georgel P, Criswell LA, Sibilia J, Mariette X, Alsaleh G, Gottenberg JE, Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjögren’s syndrome, J. Autoimmun. 2014 Jun;51:57-66.
• 2013
  Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, Kochi Y, Ohmura K, Suzuki A, Yoshida S, Graham RR, Manoharan A, Ortmann W, Bhangale T, Denny JC, Carroll RJ, Eyler AE, Greenberg JD, Kremer JM, Pappas DA, Jiang L, Yin J, Ye L, Su DF, Yang J, Xie G, Keystone E, Westra HJ, Esko T, Metspalu A, Zhou X, Gupta N, Mirel D, Stahl EA, Diogo D, Cui J, Liao K, Guo MH, Myouzen K, Kawaguchi T, Coenen MJ, van Riel PL, van de Laar MA, Guchelaar HJ, Huizinga TW, Dieudé P, Mariette X, Bridges SL, Zhernakova A, Toes RE, Tak PP, Miceli-Richard C, Bang SY, Lee HS, Martin J, Gonzalez-Gay MA, Rodriguez-Rodriguez L, Rantapää-Dahlqvist S, Arlestig L, Choi HK, Kamatani Y, Galan P, Lathrop M, , , Eyre S, Bowes J, Barton A, de Vries N, Moreland LW, Criswell LA, Karlson EW, Taniguchi A, Yamada R, Kubo M, Liu JS, Bae SC, Worthington J, Padyukov L, Klareskog L, Gregersen PK, Raychaudhuri S, Stranger BE, De Jager PL, Franke L, Visscher PM, Brown MA, Yamanaka H, Mimori T, Takahashi A, Xu H, Behrens TW, Siminovitch KA, Momohara S, Matsuda F, Yamamoto K, Plenge RM, Genetics of rheumatoid arthritis contributes to biology and drug discovery, Nature 2014 Feb;506(7488):376-81.
• 2013
  Nocturne G, Boudaoud S, Miceli-Richard C, Viengchareun S, Lazure T, Nititham J, Taylor KE, Ma A, Busato F, Melki J, Lessard CJ, Sivils KL, Dubost JJ, Hachulla E, Gottenberg JE, Lombès M, Tost J, Criswell LA, Mariette X, Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren’s syndrome, Blood 2013 Dec;122(25):4068-76.
• 2013
  Lessard CJ, Li H, Adrianto I, Ice JA, Rasmussen A, Grundahl KM, Kelly JA, Dozmorov MG, Miceli-Richard C, Bowman S, Lester S, Eriksson P, Eloranta ML, Brun JG, Gøransson LG, Harboe E, Guthridge JM, Kaufman KM, Kvarnström M, Jazebi H, Cunninghame Graham DS, Grandits ME, Nazmul-Hossain AN, Patel K, Adler AJ, Maier-Moore JS, Farris AD, Brennan MT, Lessard JA, Chodosh J, Gopalakrishnan R, Hefner KS, Houston GD, Huang AJ, Hughes PJ, Lewis DM, Radfar L, Rohrer MD, Stone DU, Wren JD, Vyse TJ, Gaffney PM, James JA, Omdal R, Wahren-Herlenius M, Illei GG, Witte T, Jonsson R, Rischmueller M, Rönnblom L, Nordmark G, Ng WF, , Mariette X, Anaya JM, Rhodus NL, Segal BM, Scofield RH, Montgomery CG, Harley JB, Sivils KL, Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren’s syndrome, Nat. Genet. 2013 Nov;45(11):1284-92.
• 2013
  Sellam J, Rouanet S, Hendel-Chavez H, Miceli-Richard C, Combe B, Sibilia J, Le Loët X, Tebib J, Jourdan R, Dougados M, Taoufik Y, Mariette X, CCL19, a B cell chemokine, is related to the decrease of blood memory B cells and predicts the clinical response to rituximab in patients with rheumatoid arthritis, Arthritis Rheum. 2013 Sep;65(9):2253-61.
• 2013
  Rusakiewicz S, Nocturne G, Lazure T, Semeraro M, Flament C, Caillat-Zucman S, Sène D, Delahaye N, Vivier E, Chaba K, Poirier-Colame V, Nordmark G, Eloranta ML, Eriksson P, Theander E, Forsblad-d'Elia H, Omdal R, Wahren-Herlenius M, Jonsson R, Rönnblom L, Nititham J, Taylor KE, Lessard CJ, Sivils KL, Gottenberg JE, Criswell LA, Miceli-Richard C, Zitvogel L, Mariette X, NCR3/NKp30 contributes to pathogenesis in primary Sjogren’s syndrome, Sci Transl Med 2013 Jul;5(195):195ra96.
• 2013
  Gottenberg JE, Seror R, Miceli-Richard C, Benessiano J, Devauchelle-Pensec V, Dieude P, Dubost JJ, Fauchais AL, Goeb V, Hachulla E, Hatron PY, Larroche C, Le Guern V, Morel J, Perdriger A, Puéchal X, Rist S, Saraux A, Sene D, Sibilia J, Vittecoq O, Nocturne G, Ravaud P, Mariette X, Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren’s syndrome. Data at enrollment in the prospective ASSESS cohort, PLoS ONE 2013;8(5):e59868.
• 2013
  Schilte C, Staikowsky F, Couderc T, Madec Y, Carpentier F, Kassab S, Albert ML, Lecuit M, Michault A, , Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study., PLoS Negl Trop Dis 2013 ; 7(3): e2137.
• 2012
  Briot K, Durnez A, Paternotte S, Miceli-Richard C, Dougados M, Roux C, Bone oedema on MRI is highly associated with low bone mineral density in patients with early inflammatory back pain: results from the DESIR cohort, Ann. Rheum. Dis. 2013 Dec;72(12):1914-9.
• 2012
  Gestermann N, Koutero M, Belkhir R, Tost J, Mariette X, Miceli-Richard C, Methylation profile of the promoter region of IRF5 in primary Sjögren’s syndrome, Eur. Cytokine Netw. 2012 Oct-Dec;23(4):166-72.
• 2012
  Wendling D, Prati C, Demattei C, Miceli-Richard C, Daures JP, Dougados M, Impact of uveitis on the phenotype of patients with recent inflammatory back pain: data from a prospective multicenter French cohort, Arthritis Care Res (Hoboken) 2012 Jul;64(7):1089-93.
• 2012
  Schilte C, Buckwalter MR, Laird ME, Diamond MS, Schwartz O, Albert ML, Cutting edge: independent roles for IRF-3 and IRF-7 in hematopoietic and nonhematopoietic cells during host response to Chikungunya infection, J. Immunol. 2012 Apr;188(7):2967-71.
• 2012
  Mariette X, Baron G, Tubach F, Lioté F, Combe B, Miceli-Richard C, Flipo RM, Goupille P, Allez M, Salmon D, Emilie D, Carcelain G, Ravaud P, Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy, Ann. Rheum. Dis. 2012 Nov;71(11):1783-90.
• 2011
  Werneke SW, Schilte C, Rohatgi A, Monte KJ, Michault A, Arenzana-Seisdedos F, Vanlandingham DL, Higgs S, Fontanet A, Albert ML, Lenschow DJ, ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation, PLoS Pathog. 2011 Oct;7(10):e1002322.
• 2011
  Mekinian A, Tamouza R, Pavy S, Gestermann N, Ittah M, Mariette X, Miceli-Richard C, Functional study of TNF-α promoter polymorphisms: literature review and meta-analysis, Eur. Cytokine Netw. 2011 Jun;22(2):88-102.
• 2011
  Lepelley A, Louis S, Sourisseau M, Law HK, Pothlichet J, Schilte C, Chaperot L, Plumas J, Randall RE, Si-Tahar M, Mammano F, Albert ML, Schwartz O, Innate sensing of HIV-infected cells, PLoS Pathog. 2011 Feb;7(2):e1001284.
• 2010
  Ittah M, Miceli-Richard C, Lebon P, Pallier C, Lepajolec C, Mariette X, Induction of B cell-activating factor by viral infection is a general phenomenon, but the types of viruses and mechanisms depend on cell type, J Innate Immun 2011;3(2):200-7.
• 2010
  Richez C, Barnetche T, Miceli-Richard C, Blanco P, Moreau JF, Rifkin I, Schaeverbeke T, Role for interferon regulatory factors in autoimmunity, Joint Bone Spine 2010 Dec;77(6):525-31.
• 2010
  Schilte C, Couderc T, Chretien F, Sourisseau M, Gangneux N, Guivel-Benhassine F, Kraxner A, Tschopp J, Higgs S, Michault A, Arenzana-Seisdedos F, Colonna M, Peduto L, Schwartz O, Lecuit M, Albert ML, , Type I IFN controls chikungunya virus via its action on nonhematopoietic cells., J Exp Med 2010 Feb; 207(2): 429-42.
• 2009
  Pavy S, Toonen EJ, Miceli-Richard C, Barrera P, van Riel PL, Criswell LA, Mariette X, Coenen MJ, Tumour necrosis factor alpha -308G->A polymorphism is not associated with response to TNFalpha blockers in Caucasian patients with rheumatoid arthritis: systematic review and meta-analysis, Ann. Rheum. Dis. 2010 Jun;69(6):1022-8.
• 2009
  Sellam J, Proulle V, Jüngel A, Ittah M, Miceli Richard C, Gottenberg JE, Toti F, Benessiano J, Gay S, Freyssinet JM, Mariette X, Increased levels of circulating microparticles in primary Sjögren’s syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity, Arthritis Res. Ther. 2009;11(5):R156.
• 2009
  Gottenberg JE, Miceli-Richard C, Ducot B, Goupille P, Combe B, Mariette X, Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort, Arthritis Res. Ther. 2009;11(4):R114.
• 2009
  Miceli-Richard C, Gestermann N, Ittah M, Comets E, Loiseau P, Puechal X, Hachulla E, Gottenberg JE, Lebon P, Becquemont L, Mariette X, The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren’s syndrome, Arthritis Rheum. 2009 Jul;60(7):1991-7.
• 2009
  Zinovieva E, Bourgain C, Kadi A, Letourneur F, Izac B, Said-Nahal R, Lebrun N, Cagnard N, Vigier A, Jacques S, Miceli-Richard C, Garchon HJ, Heath S, Charon C, Bacq D, Boland A, Zelenika D, Chiocchia G, Breban M, Comprehensive linkage and association analyses identify haplotype, near to the TNFSF15 gene, significantly associated with spondyloarthritis, PLoS Genet. 2009 Jun;5(6):e1000528.
• 2009
  Miceli-Richard C, Gestermann N, Amiel C, Sellam J, Ittah M, Pavy S, Urrutia A, Girauld I, Carcelain G, Venet A, Mariette X, Effect of methotrexate and anti-TNF on Epstein-Barr virus T-cell response and viral load in patients with rheumatoid arthritis or spondylarthropathies, Arthritis Res. Ther. 2009;11(3):R77.
• 2009
  Ittah M, Miceli-Richard C, Gottenberg JE, Sellam J, Lepajolec C, Mariette X, B-cell-activating factor expressions in salivary epithelial cells after dsRNA virus infection depends on RNA-activated protein kinase activation, Eur. J. Immunol. 2009 May;39(5):1271-9.
• 2008
  Ittah M, Miceli-Richard C, Gottenberg JE, Sellam J, Eid P, Lebon P, Pallier C, Lepajolec C, Mariette X, Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways, Eur. J. Immunol. 2008 Apr;38(4):1058-64.
• 2007
  Miceli-Richard C, Comets E, Loiseau P, Puechal X, Hachulla E, Mariette X, Association of an IRF5 gene functional polymorphism with Sjögren’s syndrome, Arthritis Rheum. 2007 Dec;56(12):3989-94.
• 2007
  Miceli-Richard C, Dieude P, Hachulla E, Puechal X, Cornelis F, Mariette X, Tumour necrosis factor receptor 2 (TNFRSF1B) association study in Sjögren’s syndrome, Ann. Rheum. Dis. 2007 Dec;66(12):1684-5.
• 2007
  Pham T, Fautrel B, Dernis E, Goupille P, Guillemin F, Le Loët X, Ravaud P, Claudepierre P, Miceli-Richard C, de Bandt M, Breban M, Maillefert JF, Masson C, Saraux A, Schaeverbeke T, Wendling D, Mariette X, Combe B, , Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with ankylosing spondylitis or psoriatic arthritis: 2007 update, Joint Bone Spine 2007 Dec;74(6):638-46.
• 2007
  Salliot C, Gottenberg JE, Bengoufa D, Desmoulins F, Miceli-Richard C, Mariette X, Anticentromere antibodies identify patients with Sjögren’s syndrome and autoimmune overlap syndrome, J. Rheumatol. 2007 Nov;34(11):2253-8.
• 2007
  Miceli-Richard C, Mariette X, EBV-specific T-cell response and immunosuppression by methotrexate and TNFalpha antagonists in patients with chronic inflammatory joint disease, Joint Bone Spine 2007 Dec;74(6):560-2.
• 2007
  Gottenberg JE, Loiseau P, Azarian M, Chen C, Cagnard N, Hachulla E, Puechal X, Sibilia J, Charron D, Mariette X, Miceli-Richard C, CTLA-4 +49A/G and CT60 gene polymorphisms in primary Sjögren syndrome, Arthritis Res. Ther. 2007;9(2):R24.
• 2006
  Sellam J, Miceli-Richard C, Gottenberg JE, Ittah M, Lavie F, Lacabaratz C, Gestermann N, Proust A, Lambotte O, Mariette X, Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren’s syndrome and systemic lupus erythematosus, Ann. Rheum. Dis. 2007 Jun;66(6):790-7.
• 2006
  Lazure T, Miceli-Richard C, Sellam J, Fabre M, Mariette X, Guettier C, Small hepatic vein involvement in IgG multiple myeloma: a very unusual pattern of liver infiltration, Virchows Arch. 2007 Jan;450(1):127-9.
• 2006
  Lavie F, Miceli-Richard C, Ittah M, Sellam J, Gottenberg JE, Mariette X, Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production, Ann. Rheum. Dis. 2007 May;66(5):700-3.
• 2006
  Pham T, Guillemin F, Claudepierre P, Luc M, Miceli-Richard C, Fautrel B, de Bandt M, Breban M, Goupille P, Maillefert JF, Masson C, Saraux A, Schaeverbeke T, Wendling D, Mariette X, Combe B, , , TNFalpha antagonist therapy in ankylosing spondylitis and psoriatic arthritis: recommendations of the French Society for Rheumatology, Joint Bone Spine 2006 Oct;73(5):547-53.
• 2006
  Gottenberg JE, Pallier C, Ittah M, Lavie F, Miceli-Richard C, Sellam J, Nordmann P, Cagnard N, Sibilia J, Mariette X, Failure to confirm coxsackievirus infection in primary Sjögren’s syndrome, Arthritis Rheum. 2006 Jun;54(6):2026-8.
• 2006
  Breban M, Miceli-Richard C, Zinovieva E, Monnet D, Said-Nahal R, The genetics of spondyloarthropathies, Joint Bone Spine 2006 Jul;73(4):355-62.
• 2006
  Ittah M, Miceli-Richard C, Eric Gottenberg J, Lavie F, Lazure T, Ba N, Sellam J, Lepajolec C, Mariette X, B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren’s syndrome, Arthritis Res. Ther. 2006;8(2):R51.
• 2006
  Gottenberg JE, Sellam J, Ittah M, Lavie F, Proust A, Zouali H, Sordet C, Sibilia J, Kimberly RP, Mariette X, Miceli-Richard C, No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren’s syndrome, Arthritis Res. Ther. 2006;8(1):R30.
• 2005
  Porcher R, Said-Nahal R, D'Agostino MA, Miceli-Richard C, Dougados M, Breban M, Two major spondylarthropathy phenotypes are distinguished by pattern analysis in multiplex families, Arthritis Rheum. 2005 Apr;53(2):263-71.
• 2004
  Priori R, Bombardieri M, Spinelli FR, Merlin F, Miceli-Richard C, La Cava M, Scavalli AS, Guerrisi R, Hugot JP, Valesini G, Sporadic Blau syndrome with a double CARD15 mutation. Report of a case with lifelong follow-up, Sarcoidosis Vasc Diffuse Lung Dis 2004 Oct;21(3):228-31.
• 2004
  Miceli-Richard C, Zouali H, Said-Nahal R, Lesage S, Merlin F, De Toma C, Blanche H, Sahbatou M, Dougados M, Thomas G, Breban M, Hugot JP, , Significant linkage to spondyloarthropathy on 9q31-34, Hum. Mol. Genet. 2004 Aug;13(15):1641-8.
• 2004
  Lavie F, Miceli-Richard C, Quillard J, Roux S, Leclerc P, Mariette X, Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren’s syndrome, J. Pathol. 2004 Apr;202(4):496-502.
• 2003
  Breban M, Said-Nahal R, Hugot JP, Miceli-Richard C, Familial and genetic aspects of spondyloarthropathy, Rheum. Dis. Clin. North Am. 2003 Aug;29(3):575-94.
• 2003
  Miceli-Richard C, van der Heijde D, Dougados M, Spondyloarthropathy for practicing rheumatologists: diagnosis, indication for disease-controlling antirheumatic therapy, and evaluation of the response, Rheum. Dis. Clin. North Am. 2003 Aug;29(3):449-62.
• 2003
  Miceli-Richard C, Dougados M, Leflunomide for the treatment of rheumatoid arthritis, Expert Opin Pharmacother 2003 Jun;4(6):987-97.
• 2002
  Miceli-Richard C, Zouali H, Lesage S, Thomas G, Hugot JP, Said-Nahal R, Breban M, CARD15/NOD2 analyses in spondylarthropathy, Arthritis Rheum. 2002 May;46(5):1405-6.